Beihai Gofar Soars 8.51% to Hit Intraday High of CNY 6.51

Beihai Gofar Chuanshan Biological Co., Ltd. has experienced a significant uptick in its stock performance, gaining 8.51% on March 24, 2026. The stock reached an intraday high of CNY 6.51, marking a notable achievement for the small-cap company in the Pharmaceuticals & Biotechnology sector. In comparison to the broader market, Beihai Gofar's one-day performance outpaced the China Shanghai Composite, which rose by 1.78%. Over the past week, the company has shown resilience with a 7.62% increase, while the Shanghai Composite declined by 4.16%. Despite a challenging month with a slight decrease of 2.69%, Beihai Gofar has demonstrated a solid year-to-date performance of 6.21%, contrasting with the Shanghai Composite's negative return of 2.21%. Over the past year, the company has achieved a return of 16.28%, slightly above the Shanghai Composite's 15.17%. While the stock's recent activity is noteworthy, it is essential to consider the company's long-term growth metrics and management efficiency, which indicate areas for improvement.